Qibin Zhang Selected Research

Fatty Liver

1/2020	Human GDPD3 overexpression promotes liver steatosis by increasing lysophosphatidic acid production and fatty acid uptake.
1/2020	Paneth Cell Dysfunction Mediates Alcohol-related Steatohepatitis Through Promoting Bacterial Translocation in Mice: Role of Zinc Deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qibin Zhang Research Topics

Disease

8	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2021 - 08/2010
8	Diabetes Complications 11/2018 - 01/2007
7	Inflammation (Inflammations) 12/2023 - 01/2019
6	Diabetes Mellitus 01/2022 - 01/2007
4	Infections 10/2021 - 01/2010
3	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023 - 06/2007
3	Type 2 Diabetes Mellitus (MODY) 01/2019 - 05/2008
2	Neoplasms (Cancer) 12/2023 - 12/2009
2	Fibrosis (Cirrhosis) 07/2022 - 01/2010
2	Dysbiosis 07/2022 - 01/2020
2	Virus Diseases (Viral Diseases) 10/2021 - 01/2014
2	Fatty Liver 01/2020 - 01/2020
2	Pathologic Processes 01/2019 - 11/2018
1	Bone Resorption 01/2023
1	Myalgia 01/2023
1	Insulinoma 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Alcoholic Hepatitis 10/2021
1	Hepatitis 10/2021
1	Hepatitis A (Hepatitis, Infectious) 10/2021
1	Body Weight (Weight, Body) 10/2021
1	Alcoholic Fatty Liver 01/2020
1	Insulin Resistance 01/2019
1	Ulcerative Colitis 08/2015
1	Crohn Disease (Crohn's Disease) 08/2015
1	Pathologic Constriction (Stenosis) 08/2015
1	Hyperglycemia 07/2011
1	Chronic Disease (Chronic Diseases) 02/2009
1	Glucose Intolerance 05/2008

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2007
7	LipidsIBA 12/2023 - 08/2010
7	Peptides (Polypeptides)IBA 01/2022 - 01/2007
4	OxylipinsIBA 12/2023 - 01/2019
4	Insulin (Novolin)FDA Link 10/2023 - 01/2019
4	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 01/2007
4	Blood Proteins (Serum Proteins)IBA 03/2021 - 01/2013
3	GangliosidesIBA 12/2023 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 09/2019 - 12/2009
3	Glycated ProteinsIBA 02/2009 - 06/2007
2	CytokinesIBA 01/2023 - 10/2021
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 01/2010
1	Carotenoids (Carotene)IBA 12/2023
1	SugarsIBA 12/2023
1	PolyphenolsIBA 12/2023
1	VitaminsIBA 12/2023
1	HDL CholesterolIBA 10/2023
1	Triglycerides (Triacylglycerol)IBA 10/2023
1	astaxanthine (astaxanthin)IBA 01/2023
1	Deubiquitinating EnzymesIBA 01/2023
1	ChitosanIBA 07/2022
1	Immunoglobulin E (IgE)IBA 07/2022
1	Liposomes (Liposome)IBA 07/2022
1	Emodin (Archin)IBA 07/2022
1	Ribosomal DNA (rDNA)IBA 07/2022
1	Deoxycholic Acid (Sodium Deoxycholate)IBA 07/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	LigandsIBA 01/2022
1	RotenoneIBA 01/2022
1	ThapsigarginIBA 01/2022
1	GlucosidasesIBA 10/2021
1	CatalaseIBA 10/2021
1	Polysaccharides (Glycans)IBA 10/2021
1	Antiviral Agents (Antivirals)IBA 10/2021
1	Alanine Transaminase (SGPT)IBA 10/2021
1	Interferon Receptors (Interferon Receptor)IBA 10/2021
1	Cytokine Receptors (Cytokine Receptor)IBA 10/2021
1	ChemokinesIBA 10/2021
1	miglustat (Zavesca)FDA Link 10/2021
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2020
1	lysophosphatidic acidIBA 01/2020
1	sialogangliosidesIBA 01/2020
1	DefensinsIBA 01/2020
1	ZincIBA 01/2020
1	Chemokine CXCL1IBA 01/2020
1	Lipocalin-2IBA 01/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2019
1	AutoantibodiesIBA 10/2018
1	ProteomeIBA 08/2015
1	RNA (Ribonucleic Acid)IBA 01/2014
1	EnzymesIBA 01/2010
1	Advanced Glycation End ProductsIBA 02/2009
1	benzeneboronic acidIBA 06/2007
1	Tyrosine (L-Tyrosine)FDA Link 06/2007

Therapy/Procedure

2	Glycemic Control 03/2021 - 01/2020
1	Therapeutics 07/2022
1	Enema (Enemas) 07/2022
1	Immunotherapy 01/2022